-
ADB approves USD 1.5 bn loan to India for purchasing COVID-19 vaccines
November 25, 2021The Asian Development Bank has approved a USD 1.5 billion (around Rs 11,185 crore) loan to...
-
Delta variant can be tackled with vaccine and control strategy: Study
November 24, 2021A new study has revealed that a vaccine is needed to fight against the Delta variant...
-
India exported over 65 million doses of Covid vaccines this year: PM Modi
November 19, 2021India exported more than 65 million doses of Covid vaccines to nearly 100 countries this year,...
-
Vaccine hesitancy greatest threat in overcoming Covid: Adar Poonawalla
November 18, 2021Serum Institute of India CEO Adar Poonawalla on Wednesday termed vaccine hesitancy as the greatest threat...
-
Covaxin 77.8% effective against Covid, no safety concerns: Lancet study
November 12, 2021The coronavirus vaccine developed by Bharat Biotech is ‘highly efficacious’ and presents no safety concern, according...
-
Natural resistance to COVID-19 infection could lead to better vaccines: Researchers
November 11, 2021Researchers believe understanding how some people naturally resist COVID-19 infection, despite clearly being exposed to the...
-
Ideal time for booster dose for COVID vaccine is 6 months after 2nd dose: Bharat Biotech MD
November 10, 2021The ideal time for a booster dose for COVID-19 vaccine is six months after the second...
-
India to buy 10mn doses of Zydus Cadilla’s Covid Vaccine at Rs 265 each
November 8, 2021Drug maker Zydus Cadila has received supplu order of 10 million doses of Covid vaccine ZyCoV-D...
-
Pfizer claims its COVID-19 pill can cut hospitalization and death by 89%
November 6, 2021Not to be left behind, Pfizer has revealed the world’s second COVID-19 antiviral pill which can...
-
Britain becomes first country in the world to approve Merck’s COVID-19 antiviral pill
November 5, 2021The UK medicines regulator has approved molnupiravir, making Britain the first country in the world to...
